Development of resistance to <scp>FGFR</scp> inhibition in urothelial carcinoma via multiple pathways <i>in vitro</i>-Reference-Cited by-同舟云学术

Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro

Published:2022-12-13 Issue:2 Volume:259 Page:220-232
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Pettitt Geoffrey A¹,Hurst Carolyn D¹^ORCID,Khan Zubeda¹,McPherson Helen R¹^ORCID,Dunning Matthew C¹,Alder Olivia¹^ORCID,Platt Fiona M¹,Black Emma VI¹^ORCID,Burns Julie E¹^ORCID,Knowles Margaret A¹^ORCID

Affiliation:

1. Division of Molecular Medicine, Leeds Institute of Medical Research at St James's St James's University Hospital Leeds UK

Funder

Yorkshire Cancer Research

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.6034

Reference64 articles.

1. Advances and challenges in targeting FGFR signalling in cancer

2. Dysregulated FGF signalling in neoplastic disorders

3. FGFR1 Amplification in Squamous Cell Carcinoma of The Lung

4. Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

5. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups;Courjal F;Cancer Res,1997

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies;Signal Transduction and Targeted Therapy;2024-08-14